
Fathoming Focal Segmental Glomerulosclerosis 9: The Genetic Testing Frontier
Uncover how genetic testing revolutionizes FSGS 9 diagnosis, offering personalized treatment, early detection, and informed family planning for improved outcomes.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Uncover how genetic testing revolutionizes FSGS 9 diagnosis, offering personalized treatment, early detection, and informed family planning for improved outcomes.

Unravel FTD/ALS2 with genetic testing. Detect UBQLN2 mutations for early diagnosis, personalized treatments, family planning, and research advancements.

Unlock insights into Generalized Epilepsy with Febrile Seizures Plus, Type 9. Learn how genetic testing aids in diagnosis and personalized treatment plans.

Explore how genetic testing can help identify mutations in glucocorticoid resistance, guide personalized treatment, predict disease progression, and aid family planning.

Explore Hennekam Syndrome 2, a rare genetic disorder, and the crucial role of genetic testing in diagnosis, management, and family planning. Empower your journey.

Explore Hyperlipoproteinemia Type 1D, a genetic disorder affecting lipid metabolism. Learn how genetic testing aids in diagnosis, personalized treatment, and management.

Explore how genetic testing enhances diagnosis and treatment of Hyperphosphatasia with Intellectual Disability Syndrome 5, unlocking a personalized healthcare approach.

Genetic testing aids in diagnosing hyperproinsulinemia, linking genetic markers to the condition, enhancing risk assessment, and personalizing treatment plans effectively.